Bradley-Kennedy C, Wolowacz SE, Roskell NS. Cost-effectiveness of dabigatran etexilate in Canada for the primary prevention of venous thromboembolism in patients undergoing total knee or total hip replacement surgery. Poster presented at the International Society on Thrombosis and Haemostasis 22nd International Congress; July 11, 2009. Boston, MA.

Abstract not available at this time

Share on: